Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bitzer

Showing results (831-840 of 880) with videos related to

Pageof 88
Sort By:
The Journal of Clinical Investigation|January 13, 2023
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetesJennifer A Schaub, Fadhl M AlAkwaa, Phillip J McCown, et al.
Nature Cancer|February 5, 2022
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerRamona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2022
Preexisting comorbidities shape the immune response associated with severe COVID-19Stefanie Kreutmair, Manuel Kauffmann, Susanne Unger, et al.
NPJ Vaccines|June 10, 2024
Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in miceM Allison Wolf, Joanne M O'Hara, Graham J Bitzer, et al.
Diabetes|November 4, 2022
Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation With Progression of Diabetic Kidney DiseaseJiahao Liu, Viji Nair, Yi-Yang Zhao, et al.
The Lancet. Gastroenterology & Hepatology|August 6, 2021
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 studyMilind Javle, Sameek Roychowdhury, Robin Kate Kelley, et al.
JCI Insight|May 20, 2026
Not all reference samples are equal in single-cell transcriptomics of human kidney tissueRajasree Menon, Paul L Kimmel, Edgar A Otto, et al.
Genome Biology|March 13, 2026
Systematic evaluation of single-cell multimodal data integration enhances cell type resolution and discovery of clinically relevant states in complex tissuesMario Acera-Mateos, Xian Adiconis, Jessica-Kanglin Li, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Systematic evaluation of single-cell multimodal data integration for comprehensive human reference atlasMario Acera-Mateos, Xian Adiconis, Jessica-Kanglin Li, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Pageof 88

Showing results (831-840 of 880) with videos related to

Sort By:
Pageof 88
The Journal of Clinical Investigation|January 13, 2023
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetesJennifer A Schaub, Fadhl M AlAkwaa, Phillip J McCown, et al.
Nature Cancer|February 5, 2022
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerRamona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, et al.
The Journal of Allergy and Clinical Immunology|June 18, 2022
Preexisting comorbidities shape the immune response associated with severe COVID-19Stefanie Kreutmair, Manuel Kauffmann, Susanne Unger, et al.
NPJ Vaccines|June 10, 2024
Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in miceM Allison Wolf, Joanne M O'Hara, Graham J Bitzer, et al.
Diabetes|November 4, 2022
Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation With Progression of Diabetic Kidney DiseaseJiahao Liu, Viji Nair, Yi-Yang Zhao, et al.
The Lancet. Gastroenterology & Hepatology|August 6, 2021
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 studyMilind Javle, Sameek Roychowdhury, Robin Kate Kelley, et al.
JCI Insight|May 20, 2026
Not all reference samples are equal in single-cell transcriptomics of human kidney tissueRajasree Menon, Paul L Kimmel, Edgar A Otto, et al.
Genome Biology|March 13, 2026
Systematic evaluation of single-cell multimodal data integration enhances cell type resolution and discovery of clinically relevant states in complex tissuesMario Acera-Mateos, Xian Adiconis, Jessica-Kanglin Li, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Systematic evaluation of single-cell multimodal data integration for comprehensive human reference atlasMario Acera-Mateos, Xian Adiconis, Jessica-Kanglin Li, et al.
Nature Communications|October 27, 2022
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaJens Bauer, Natalie Köhler, Yacine Maringer, et al.
Pageof 88